Back to search

United Kingdom· GB-APID-4608311000001102

Evra transdermal patches

A norelgestromin and ethinylestradiol product containing ethinylestradiol + norelgestromin, registered in United Kingdom by Gedeon Richter (UK) Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC G03AA13

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedEvra transdermal patchesATCG03AA13REGISTER NO.GB-APID-4608311000001…PACKS LISTED3CHECKEDSeptember 13, 2026

Where it is registered

Norelgestromin and ethinylestradiol is registered in 11 of 19 countries.

Countries holding a registration under ATC G03AA13 (norelgestromin and ethinylestradiol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Norelgestromin and ethinylestradiol · ATC G03AA13

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ethinylestradiol + Norelgestromin
Manufacturer
Gedeon Richter (UK) Ltd
Country
United Kingdom (GB)
ATC code
G03AA13
ATC class
Norelgestromin and ethinylestradiol
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5012674901052
  • gtin
    05012674901052
  • gtin
    5997001328156

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

33 interactions on record for norelgestromin and ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Norelgestromin and ethinylestradiol · interactions on record

33 records

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Norelgestromin and ethinylestradiol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norelgestromin and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Evra
  • Liechtenstein · Evra
  • Norway · Evra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a1868e06-49ba-4549-9a69-0302c04b5e21
GET /v1/drugs/a1868e06-49ba-4549-9a69-0302c04b5e21?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4608311000001102",
  "desc": "Evra transdermal patches (Gedeon Richter (UK) Ltd)",
  "form": "Transdermal patch",
  "vpid": "4639611000001105",
  "source": "dmd",
  "vtm_id": "775867002",
  "strength": "203 microgram",
  "substance": "Ethinylestradiol + Norelgestromin",
  "ingredient": "Norelgestromin",
  "supplier_code": "20177411000001101"
}

See everything about norelgestromin and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.